Skip to content

Clinical trials

Terminated Phase 2 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2 Status: Terminated Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20074
20082
20091
20103
20111
20123
20131
20143
20152
20161
20181
20192
20203
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
Genaera Corporation3
Asociación para Evitar la Ceguera en México2
Gemini Therapeutics, Inc.2
Genentech, Inc.2
Novartis Pharmaceuticals2
Ophthotech Corporation2
Alcon Research1
Alimera Sciences1
Anne Fung MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration33
Geographic Atrophy7
Choroidal Neovascularization6
Retinal Degeneration3
Retinal Diseases3
Eye Diseases1
Retinal Detachment1
Wet Macular Degeneration1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.